Skip to content

Clinical trial of evaluation of pain control in orthopaedic surgery after adding magnesium sulfate to fentanyl infusion

Clinical trial of evaluation of pain control in orthopaedic surgery after adding magnesium sulfate to fentanyl infusion

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201411017984N21
Enrollment
80
Registered
2015-01-04
Start date
2013-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical trial of evaluation of pain control in orthopaedic surgery after adding magnesium sulfate to fentanyl infusion. Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention 1: Group 1 (magnesium sulfate ) 40 patients, we infused fentanyl plus magnesium sulfate in ordered below: 30mg/kg sulfate magnesium in 250 cc sodium chloride (over 10 minute) and then 10
Treatment - Drugs
Group 1 (magnesium sulfate ) 40 patients, we infused fentanyl plus magnesium sulfate in ordered below: 30mg/kg sulfate magnesium in 250 cc sodium chloride (over 10 minute) and then 10 mg/kg for 48 hou
In control group (40 patients) we infused the 250cc sodium chroride over 10 minutes and then the equal volume of magnesium sulfate were infused.

Sponsors

Vice chancellor for research , Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : patients with the age group of 20 to 50 years? patients with ASA I, II , orthopedic surgery will be done under the same procedure with General anesthesia and the surgical team are the same . Exclusion criteria : Patients who have major disease of liver? kidney? cardiovascular? asthma and COPD ? patients were treated with calcium channel blocker.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 1 , 6 , 12 , 18 , 24 , 48. Method of measurement: Visual analogue scale (VAS).

Secondary

MeasureTime frame
Sedation. Timepoint: First and 1,6,12,18,24,48 hours later. Method of measurement: Ramsay score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKarim Hemati

Iran University of Medical Sciences

khematy@gmail.com+98 216653921

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026